“Lasmiditan for the Acute Treatment of Migraine: Subgroup Analyses by Prior Response to Triptans”. Headache Medicine, vol. 11, no. 3, Sept. 2020, p. 78, https://doi.org/10.48208/HeadacheMed.2020.22.